Evidence of immune activation in IBS includes elevated levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-8, and tumor necrosis factor-α (Brzozowski et al., 2016; Seyedmirzaee et al., 2016; Ivashkin et al., 2021). Here, IL6 is linked to irritable bowel syndrome.